CMPX
CMPX
US20454B1044
Compass Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
178.83M EUR
394.39M EUR
952.67M EUR
957.6M EUR
Enterprise Value
6.85M EUR
368.57M EUR
907.29M EUR
936.79M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-1.85x
--
--
--
Price to Sales
--
--
--
--
Price to Book
1.08x
2.38x
5.11x
4.87x
EV/Revenue
--
--
--
--
EV/EBITDA
-0.09x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-17.54%
-14.29%
-5.59%
-3.75%
ende